Physician profile
Jeffrey E Johnson
NPI 1275551699
$944,125.48
in general payments reported to CMS, 2019-2025
14 companies · $128 in 2025
The $128 reported for 2025 was less than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $9,426 · 2021: $208 · 2022: $917K · 2023: $2,141 · 2024: $256 · 2025: $128.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Acquisitions: $1,640 · Food and Beverage: $884.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Acquisitions | $1,640.35 |
| Food and Beverage | $884.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $918,367.33 | 2019-2024 | Motoband, Na |
| Arthrex, INC. | $18,408.06 | 2019-2021 | |
| Elite Orthopedics, LLC | $3,335.29 | 2019-2023 | |
| Ethicon INC. | $1,650.00 | 2020 | |
| Wright Medical Technology, INC. | $880.46 | 2019-2020 | |
| Stryker Corporation | $478.09 | 2019-2023 | Infinity Adaptis |
| Linvatec Corporation | $240.98 | 2024-2025 | Biobrace 23mm, Neospan |
| Medline Industries Lp | $188.08 | 2022-2023 | |
| Integra Lifesciences Corporation | $140.00 | 2019 | |
| Acera Surgical, INC. | $139.43 | 2023 | Restrata Wound Matrix |
| Axogen | $125.00 | 2020 | |
| Smith+Nephew, INC. | $104.57 | 2022 | |
| Biocomposites INC | $68.19 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$104,822.25 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.